Sept.
11 responders were significantly more likely to develop liver disease than the
general population, according to a retrospective study discussed at a recent
presscast put on by the organizers of Digestive Disease Week.
Digestive Disease Week 2020 was canceled, and while there will be no Virtual DDW, the organizers are nevertheless releasing the scientific data that was to be presented, consistent with the meeting's original schedule.
The
rate of toxin-associated fatty liver disease (TAFLD) was nearly 83% among 243 World
Trade Center first responders who were referred to a doctor for gastrointestinal
symptoms, according to abstract Mo1507. By comparison, the rate among the
general population ranges from 24 to 45%.
Between
80 and 100 million Americans have non-alcoholic fatty liver disease (NAFLD),
which is associated with obesity, type 2 diabetes, and metabolic syndrome,
according to Mishal Reja, MD, resident physician at the Robert Wood Johnson
University Hospital in New Brunswick, New Jersey.
“TAFLD
is associated with many common toxins, such as vinyl chloride, as well industrial
solvents and building demolition,” explained Reja, who presented the study.
Among
the first responders, 40% were involved with debris removal, while 30 to 40%
had administrative roles, added Reja.
The researchers
expect to begin two prospective studies to confirm the findings within the next
month. The studies will seek to enroll between one hundred and two hundred
subjects comparing the findings in non-World Trade Center responders, Reja
noted.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.